The unreliability of continuous postoperative lactate monitoring after extended hepatectomies: single center experience
- 21 February 2015
- journal article
- Published by Springer Nature in Updates in Surgery
- Vol. 67 (1) , 33-37
Abstract
Postoperative plasma lactate clearance has been established as an important prognostic factor for liver resection morbidity and mortality. The aim of this study was to analyse continuous monitoring of plasma lactate in patients submitted to extended hepatectomy (EH) with special attention to those who received preoperative portal vein branch embolization (PVE) to augment the future remnant liver. In this single center retrospective study, a full revision of 45 medical records was performed from patients who underwent EH at ISMETT from October 1999 to August 2013. Plasma lactates from admission to ICU to day 5 were recorded. Postoperative lactate clearance (ΔLAC) was defined as lactate at postoperative day 5 minus lactate at ICU presentation (hour 0). ΔLAC was analysed in relation to total hospital stay and 90 days’ perioperative morbidity and mortality, using Clavien–Dindo classification, and by presence or absence of PVE. Forty-one right and four left EH were performed. 17 patients underwent previous PVE with a mean of 44 ± 28.9 days-to-surgery time and a 24 ± 8.3 % degree of hypertrophy. In 39 cases (86.7 %), a malignant etiology was the indication for EH, length of surgery was 486 ± 122 min with a median of 300 ml of blood transfusion. In 25 patients, a Clavien grade IIIa or worst complication has been experienced, and in three cases the death occurred during the first 3 months after EH. The median length of hospitalization was 11 days. In patients with preoperative PVE a significative association with an early post-resectional lactate clearance was obtained (p 0.01). Conversely, the univariate analysis measured by t test did not show any significative associations between ΔLAC and a median time of hospital stay longer than 11 days (p 0.08), or the onset of any complications (p 0.67) and of a Clavien’s grade of complications ≥IIIa patients (p 0.48). After adjusting for co-variables, results of the multivariate logistic regression analyses confirmed that ΔLAC is not independent or significant predictor for initial poor liver function following EH. In our single center experience, the continuous monitoring of postoperative lactate clearance did not work as an early marker of postoperative liver dysfunction following EH. Although lactate clearance, worked as guide having a clinical utility in the ICU statement for hemodynamic optimization and systemic fluid balance management.Keywords
This publication has 26 references indexed in Scilit:
- Highest intraoperative lactate level could predict postoperative infectious complications after hepatectomy, reflecting the Pringle maneuver especially in chronic liver diseaseJournal of Hepato-Biliary-Pancreatic Sciences, 2014
- Point-of-care testing on admission to the intensive care unit: lactate and glucose independently predict mortalityClinical Chemistry and Laboratory Medicine (CCLM), 2012
- The Predictive Value of Postoperative Clinical Risk Scores for Outcome After Hepatic Resection: A Validation Analysis in 807 PatientsAnnals of Surgical Oncology, 2011
- Blood lactate and pyruvate levels in the perioperative period of liver resection with pringle maneuverClinical Hemorheology and Microcirculation, 2010
- Prediction of Postoperative Outcome After Hepatectomy With a New Bedside Test for Maximal Liver Function CapacityAnnals of Surgery, 2009
- Localized Hepatic Ischemia After Liver ResectionAnnals of Surgery, 2007
- Clinicopathological and intraoperative parameters associated with postoperative hepatic complications.2007
- Discordance between lactate and base deficit in the surgical intensive care unit: which one do you trust?The American Journal of Surgery, 2006
- Predictive Indices of Morbidity and Mortality After Liver ResectionAnnals of Surgery, 2006
- Correlation between peri-operative serum lactate levels and outcome in pancreatic resection for pancreatic cancer, preliminary report.2002